12:00 AM
Feb 14, 2013
 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Depression; anxiety Glucocorticoid receptor (GCCR); disrupted in schizophrenia 1 (DISC1)

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >